BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Omega-3-acid ethyl esters (Lovaza) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Omega-3-acid ethyl esters (Lovaza)\, from
  ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06195306-1150@assetmemo.bio
DTSTAMP:20261121T010013Z
DTSTART;VALUE=DATE:20270101
DTEND;VALUE=DATE:20270102
SUMMARY:Omega-3-acid ethyl esters (Lovaza): Phase 2 readout est. (NCT061953
 06)
DESCRIPTION:Omega-3-acid ethyl esters (Lovaza)\, phase 2.\nStudy: Low Dose 
 Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduc
 tion\nEstimated primary completion: 1 January 2027. This is a ClinicalTria
 ls.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pa
 ge: https://assetmemo.bio/drug/omega-3-acid-ethyl-esters-lovaza#upcoming-e
 vents\nRegistry record: https://clinicaltrials.gov/study/NCT06195306
URL:https://assetmemo.bio/drug/omega-3-acid-ethyl-esters-lovaza#upcoming-ev
 ents
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT00682318-1150@assetmemo.bio
DTSTAMP:20261121T010013Z
DTSTART;VALUE=DATE:20281130
DTEND;VALUE=DATE:20281201
SUMMARY:Omega-3-acid ethyl esters (Lovaza): Phase na readout est. (NCT00682
 318)
DESCRIPTION:Omega-3-acid ethyl esters (Lovaza)\, phase na.\nStudy: Effects 
 of Fish Oil and Red Wine on Oxidative Stress Biomarkers\nEstimated primary
  completion: November 2028. This is a ClinicalTrials.gov estimate\, not a 
 confirmed readout date\, and it can move.\nDrug page: https://assetmemo.bi
 o/drug/omega-3-acid-ethyl-esters-lovaza#upcoming-events\nRegistry record: 
 https://clinicaltrials.gov/study/NCT00682318
URL:https://assetmemo.bio/drug/omega-3-acid-ethyl-esters-lovaza#upcoming-ev
 ents
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
